BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28371837)

  • 1. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease.
    Kumar S; Baldinger SH; Kapur S; Romero J; Mehta NK; Mahida S; Fujii A; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):79-89. PubMed ID: 28940781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.
    Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F
    J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
    Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S
    Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated critical epicardial arrhythmogenic substrate abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular tachycardia.
    Tschabrunn CM; Zado ES; Schaller RD; Garcia FC; Kumareswaran R; Hsue W; Santangeli P; Marchlinski FE
    Heart Rhythm; 2022 Apr; 19(4):538-545. PubMed ID: 34883271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Romero J; Patel K; Briceno D; Alviz I; Gabr M; Diaz JC; Trivedi C; Mohanty S; Della Rocca D; Al-Ahmad A; Yang R; Rios S; Cerna L; Du X; Tarantino N; Zhang XD; Lakkireddy D; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2022-2031. PubMed ID: 32478430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of recurrent ventricular tachyarrhythmia after catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy.
    Lin CY; Chung FP; Kuo L; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chang TY; Yamada S; Te ALD; Huang TC; Chen SA
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):582-592. PubMed ID: 30699244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and transmural properties of the reentrant ventricular tachycardia circuit in arrhythmogenic right ventricular cardiomyopathy: Simultaneous epicardial and endocardial recordings.
    Jiang R; Nishimura T; Beaser AD; Aziz ZA; Upadhyay GA; Shatz DY; Nayak HM; Liao H; Zhan X; Chung FP; Xue Y; Wu S; Tung R
    Heart Rhythm; 2021 Jun; 18(6):916-925. PubMed ID: 33524624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.
    Vergara P; Trevisi N; Ricco A; Petracca F; Baratto F; Cireddu M; Bisceglia C; Maccabelli G; Della Bella P
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):621-7. PubMed ID: 22486970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.